iTechGuides is reader-supported. When you buy through links on our site, we may earn an affiliate commission. As an Amazon Associate I earn from qualifying purchases. Learn more
Newer medicines that act on incretin hormone pathways have drawn clinical attention because trials found large average weight reductions compared with placebo. In separate studies, semaglutide and tirzepatide produced substantial mean losses over roughly 16 to 17 months. Those results help explain the interest; they do not guarantee an individual result, show that every patient is eligible, or prove the drugs should be compared as if they were tested head to head.
Why are doctors paying attention to these medicines?
The interest is grounded chiefly in results that stand out against placebo in clinical trials, alongside product labels that include uses for certain weight-related conditions. Semaglutide is a GLP-1 receptor agonist. Tirzepatide acts through both GIP and GLP-1 receptor pathways. These medicines are not simply interchangeable versions of one another: their labeled uses, dosing, safety information and practical access depend on the specific product and patient.
“Frenzy” describes the public framing of the topic, not a measured finding about how enthusiastic doctors are or how often they prescribe these drugs. The evidence summarized here establishes clinical trial outcomes and regulatory information, not physician sentiment or current prescribing rates.
Free tools Windows power users keep installed
One-click scans. No signup required.
How much weight did people lose in the trials?
The following are average results at the stated follow-up points. They describe groups under study protocols, not a forecast for any one person.
#1 Best Overall
- 12 MONTH WEIGHT LOSS TRACKER Track your weight loss journey over 12 months with a guided journal designed for recording pounds lost, body measurements, goals and progress.
- POUNDS LOST & BODY MEASUREMENTS Includes 10, 20, 30, 50 and 100 pounds lost trackers, plus body measurement tracking to help you visually follow your progress over time.
- MONTHLY STEP & FITNESS TRACKERS Plan and record movement with monthly step trackers and monthly fitness planner pages, ideal for building consistency around activity and fitness goals.
- VITAMINS, SUPPLEMENTS & REFLECTIONS Includes vitamins and supplements trackers, plus goals and reflections sections to help you stay organised and review your progress throughout the year.
- CHALLENGES TO KEEP YOU MOTIVATED Features 30 day, 12 week and 52 week challenges, giving you different ways to stay focused and create momentum across your weight loss journey.
| Trial and publication | Medicine and follow-up | Mean body-weight change | Placebo result |
|---|---|---|---|
| STEP 1, New England Journal of Medicine, 2021 | Semaglutide, week 68 | −14.9%; estimated treatment difference versus placebo was −12.4 percentage points | −2.4% at week 68 |
| SURMOUNT-1, New England Journal of Medicine, 2022 | Tirzepatide 10 mg, week 72 | −19.5% | −3.1% at week 72 |
| SURMOUNT-1, New England Journal of Medicine, 2022 | Tirzepatide 15 mg, week 72 | −20.9% |
The STEP 1 and SURMOUNT-1 figures come from separate trials with different protocols and follow-up periods. They are not a randomized comparison of semaglutide against tirzepatide, so the percentages should not be read as a direct ranking of the medicines.
What does a direct comparison show?
SURMOUNT-5 was an open-label controlled trial comparing maximum tolerated doses over 72 weeks in adults with obesity without type 2 diabetes. Participants received tirzepatide at 10 mg or 15 mg, or semaglutide at 1.7 mg or 2.4 mg, once weekly. This design directly compared the medicines, unlike STEP 1 and SURMOUNT-1. The study information summarized here confirms the design but does not provide numerical outcome results, so no head-to-head weight-loss figure is stated here.
Rank #2
- FOOD JOURNAL FOR HEALTHY - A food journal to tracks daily dietary and nutritional intake for women/men. It will help you stay healthy, get motivated, get rid of bad habits, and achieve your weight loss goals. Focus on your health and eat healthy, this food tracker is all about what you want to improve.
- ACHIEVE GOALS - This fitness and nutrition journal helps you set big goals, break them down into monthly milestones, and work relentlessly toward them. At the end of each month, you will complete a monthly review to reflect your progress.
- UNDATED 6 MONTH MEAL PLANNER - This is a food diary that tracks meals and exercise last for 6 month. Keep daily records of calories, sleep time, water, weight, body fat, and activity. The monthly record can help you pay attention to your health and notice how changing your diet and lifestyle affects how you feel.
- ADDITIONAL - Lovely patterns created by hardcover, high quality of size 5.8" x 8.3", There are 3 sheets colorful stickers to help you plan and stay motivated to continue using this daily journal. What's more, the food journal with 3 ribbon bookmark, elastic band, pen holder and inner pocket for easy use.
- GUARANTEE - If you have any problems with this food journal, please contact us and we will help you solve promptly!
Even a direct trial result would need to be interpreted in light of its population, protocol and endpoints; it would not determine which medicine is right for a particular patient.
Quick wins for a faster PC:
Scan for outdated or missing drivers - takes under a minuteDriver Scan →Repair Windows errors before they cause bigger problemsFix Now →What are the labeled uses, and who may qualify?
Eligibility is specific to the medicine, indication and patient. The 2026 FDA prescribing information for Wegovy includes long-term weight reduction and maintenance for specified patients, as well as certain cardiovascular-risk and metabolic dysfunction-associated steatohepatitis (MASH) indications. These are distinct labeled uses, not evidence that losing weight automatically prevents every condition associated with obesity.
The FDA-approved Wegovy injection dose of 7.2 mg, approved March 19, 2026, is for weight loss and long-term maintenance in certain adult patients. That dose is not a general recommendation for everyone taking semaglutide; clinicians must use the current product label to determine whether a specific patient and indication fit.
The available information does not establish a single eligibility rule that applies across all products and indications. A clinician can assess the relevant label, the person’s medical history and treatment goals rather than inferring eligibility from trial averages alone.
Rank #4
- 150-day/5-month food and fitness journal with measuring tape: this fitness journal allows you to record up to 150 days of fitness and diet data, ensuring you stay on track with your health goals. The measuring tape helps you to track your body dimensions and detailed tracking system helps you monitor progress and make necessary adjustments to your routine
- Structured goal setting and achievement: the 2 goal pages of fitness planner has 10 sections for setting clear objectives, start and end dates, detailed plans, and results. The workout journal also features a reward section to motivate you to achieve your fitness milestones
- Body dimension contrasts by table, photos and chart: the body dimension contrasts can be shown by figures, photos, and progress curves. This visual representation allows you to see tangible changes in your physique over time, providing motivation and a clear sense of achievement
- Integrated calendar and daily tracking: the 2-page undated calendar of weight loss journal provides a monthly overview with daily completion marks and progress curves. The daily tracking pages allow you to log specific exercises, calories burned, and meal calorie intake. This integrated system helps you maintain a consistent routine and stay accountable to your fitness and nutrition goals
- User-friendly design, durable material: the 9.5'' * 7'' fitness journal for women is easy to carry and use, with a waterproof and sweat-proof PP material cover and ink-resistant 100gsm thick paper inside. The elastic band keeps the workout planner closed to keep your data private and organized. Double sided pockets are designed for cards, guidebooks, etc.
What side effects and warnings matter?
Wegovy label information
The 2026 Wegovy label lists nausea, diarrhea, vomiting, constipation and abdominal pain among common adverse reactions. Its boxed warning describes thyroid C-cell tumors in rodents; whether semaglutide causes these tumors in humans is unknown. Wegovy is contraindicated for people with a personal or family history of medullary thyroid carcinoma or with multiple endocrine neoplasia syndrome type 2 (MEN 2). The label includes additional warnings and precautions, so this short list is not a substitute for reviewing it with a prescriber.
FDA review of suicidal ideation and behavior
On January 13, 2026, the FDA said its review found no increased risk of suicidal ideation or behavior with GLP-1 receptor agonists and requested removal of that warning from affected labels. This is a specific FDA review and labeling update; it does not mean these medicines have no other risks.
Best Value
- SMASH YOUR PB'S - Achieve the performance and physique you've always wanted with Nextnoid daily workout journal! Effectively track both daily and weekly workout goals upto 8 months as meticulously as you desire, plan next week's workouts, and celebrate your success with ease. Stay focused!
- GET FITTER, FASTER - Take control of your health and fitness journey and accelerate your results with our fitness planner for women and men! This exercise diary provides you with a proven system to build muscle, improve strength or just be healthier. What gets measured, improves!
- SIMPLE AND CLEAR - Setting yourself up for success has never been easier! Our personal workout book takes the thought and effort out of staying disciplined and accountable with a clear incremental progress system, bigger fonts for easy reading and enough space to jot down everything.
- CAREFULLY CRAFTED - Made with functionality and also long-lasting durability in mind with size 5.7x8.3 in, this fit log journal is tough enough to withstand the rigors of the gym floor, running trail and even the kitchen! Premium thick 120gsm pages and a sweat and tear-proof outer match your grit!
- PERFECT GIFT - Show the fitness enthusiast in your life just how much you care with this workout tracker notebook! Also ideal for the beginner who dreams of being in shape, this fitness training journal could be the motivation they need to kickstart their health and wellness journey!
Are compounded versions the same as approved medicines?
No. FDA says compounded drugs are not FDA-approved and are not reviewed before marketing for safety, effectiveness or quality. It has reported dosing errors with compounded injectable semaglutide, including reports requiring hospitalization, and warns that semaglutide salt forms differ from the active ingredient used in approved drugs. FDA advises patients to obtain a prescription from a doctor and use a state-licensed pharmacy.
On April 30, 2026, the FDA announced a proposal to exclude semaglutide, tirzepatide and liraglutide from the 503B bulks list, saying it found no clinical need for outsourcing facilities to compound them from bulk drug substances. The announcement invited comments and said the agency would consider them before making a final determination. It describes a proposal, not a final rule.
What should patients know about availability and coverage?
Availability can change, and shortage information is time-sensitive. FDA records that it determined the semaglutide injection shortage was resolved on February 21, 2025; that dated update does not establish the current status of every product or local supply. Check live FDA shortage information and ask a pharmacy or prescriber about current availability.
Current prices and insurance coverage are not established here. They can vary by product, plan and patient circumstances, so confirm the details with the insurer and prescribing clinician rather than relying on a general price or coverage assumption.
How to weigh the evidence with a clinician
A useful decision is about more than which trial reported the largest percentage. Discuss the particular product and its current label, relevant medical history and contraindications, expected benefits and adverse effects, dosing routine, access and coverage. Trial averages can inform that conversation, but they cannot decide it for an individual.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
